Works by Xue, Jinqi

Results: 28

Knockdown of endothelin receptor B inhibits the progression of triple‐negative breast cancer.

Published in:

Annals of the New York Academy of Sciences, 2019, v. 1448, n. 1, p. 5, doi. 10.1111/nyas.14039

By:

Gu, Xi;
Han, Shuai;
Cui, Meizi;
Xue, Jinqi;
Ai, Liping;
Sun, Lisha;
Zhu, Xudong;
Wang, Yulun;
Liu, Caigang

Publication type:

Article

SND1 expression in breast cancer tumors is associated with poor prognosis.

Published in:

Annals of the New York Academy of Sciences, 2018, v. 1433, n. 1, p. 53, doi. 10.1111/nyas.13970

By:

Gu, Xi;
Xue, Jinqi;
Ai, Liping;
Sun, Lisha;
Zhu, Xudong;
Wang, Yulun;
Liu, Caigang

Publication type:

Article

Structure, Function, Diversity, and Composition of Fungal Communities in Rhizospheric Soil of Coptis chinensis Franch under a Successive Cropping System.

Published in:

Plants (2223-7747), 2020, v. 9, n. 2, p. 244, doi. 10.3390/plants9020244

By:

Alami, Mohammad Murtaza;
Xue, Jinqi;
Ma, Yutao;
Zhu, Dengyan;
Abbas, Aqleem;
Gong, Zedan;
Wang, Xuekui

Publication type:

Article

Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study.

Published in:

eLife, 2023, p. 1, doi. 10.7554/eLife.91737

By:

Guanglei Chen;
Xi Gu;
Jinqi Xue;
Xu Zhang;
Xiaopeng Yu;
Yu Zhang;
Ailin Li;
Yi Zhao;
Guijin He;
Meiyue Tang;
Fei Xing;
Jianqiao Yin;
Xiaobo Bian;
Ye Han;
Shuo Cao;
Chao Liu;
Xiaofan Jiang;
Keliang Zhang;
Yan Xia;
Huajun Li

Publication type:

Article

KK-LC-1 as a therapeutic target to eliminate ALDH<sup>+</sup> stem cells in triple negative breast cancer.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38097-1

By:

Bu, Jiawen;
Zhang, Yixiao;
Wu, Sijin;
Li, Haonan;
Sun, Lisha;
Liu, Yang;
Zhu, Xudong;
Qiao, Xinbo;
Ma, Qingtian;
Liu, Chao;
Niu, Nan;
Xue, Jinqi;
Chen, Guanglei;
Yang, Yongliang;
Liu, Caigang

Publication type:

Article

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02805-y

By:

Gao, Hongli;
Yin, Jianqiao;
Ji, Ce;
Yu, Xiaopeng;
Xue, Jinqi;
Guan, Xin;
Zhang, Shuang;
Liu, Xun;
Xing, Fei

Publication type:

Article

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02805-y

By:

Gao, Hongli;
Yin, Jianqiao;
Ji, Ce;
Yu, Xiaopeng;
Xue, Jinqi;
Guan, Xin;
Zhang, Shuang;
Liu, Xun;
Xing, Fei

Publication type:

Article

Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.

Published in:

World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02871-0

By:

Shen, Yanyan;
Xue, Jinqi;
Yu, Jiahui;
Jiang, Yi;
Bu, Jiawen;
Zhu, Tong;
Gu, Xi;
Zhu, Xudong

Publication type:

Article

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.

Published in:

BMC Surgery, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12893-015-0067-4

By:

Jianyi Li;
Shi Jia;
Wenhai Zhang;
Fang Qiu;
Yang Zhang;
Xi Gu;
Jinqi Xue

Publication type:

Article

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.

Published in:

BMC Surgery, 2015, v. 15, n. 1, p. 79, doi. 10.1186/s12893-015-0067-4

By:

Jianyi Li;
Shi Jia;
Wenhai Zhang;
Fang Qiu;
Yang Zhang;
Xi Gu;
Jinqi Xue

Publication type:

Article

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.

Published in:

2015

By:

Li, Jianyi;
Jia, Shi;
Zhang, Wenhai;
Qiu, Fang;
Zhang, Yang;
Gu, Xi;
Xue, Jinqi

Publication type:

journal article

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer.

Published in:

eLife, 2022, p. 1, doi. 10.7554/eLife.68481

By:

Yixiao Zhang;
Lisha Sun;
Haonan Li;
Liping Ai;
Qingtian Ma;
Xinbo Qiao;
Jie Yang;
Hao Zhang;
Xunyan Ou;
Yining Wang;
Guanglei Chen;
Jinqi Xue;
Xudong Zhu;
Yu Zhao;
Yongliang Yang;
Caigang Liu

Publication type:

Article

Curcumin alleviates glucocorticoid-induced osteoporosis by protecting osteoblasts from apoptosis in vivo and in vitro.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 2, p. 268, doi. 10.1111/1440-1681.12513

By:

Chen, Zhiguang;
Xue, Jinqi;
Shen, Tao;
Ba, Gen;
Yu, Dongdong;
Fu, Qin

Publication type:

Article

Structure, Diversity, and Composition of Bacterial Communities in Rhizospheric Soil of Coptis chinensis Franch under Continuously Cropped Fields.

Published in:

Diversity (14242818), 2020, v. 12, n. 2, p. 57, doi. 10.3390/d12020057

By:

Alami, Mohammad Murtaza;
Xue, Jinqi;
Ma, Yutao;
Zhu, Dengyan;
Gong, Zedan;
Shu, Shaohua;
Wang, Xuekui

Publication type:

Article

FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.

Published in:

SCIENCE CHINA Life Sciences, 2023, v. 66, n. 12, p. 2805, doi. 10.1007/s11427-023-2343-y

By:

Chen, Guanglei;
Sun, Lisha;
Gu, Xi;
Ai, Liping;
Yang, Jie;
Zhang, Zhan;
Hou, Pengjie;
Wang, Yining;
Ou, Xunyan;
Jiang, Xiaofan;
Qiao, Xinbo;
Ma, Qingtian;
Niu, Nan;
Xue, Jinqi;
Zhang, Hao;
Yang, Yongliang;
Liu, Caigang

Publication type:

Article

Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.

Published in:

International Journal of Molecular Medicine, 2016, v. 37, n. 2, p. 329, doi. 10.3892/ijmm.2015.2432

By:

ZHIGUANG CHEN;
JINQI XUE;
TAO SHEN;
SHUAI MU;
QIN FU

Publication type:

Article

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer.

Published in:

Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 16, p. 9125, doi. 10.1111/jcmm.15549

By:

Zhang, Yixiao;
Zhu, Xudong;
Qiao, Xinbo;
Gu, Xi;
Xue, Jinqi;
Han, Yanshuo;
Sun, Lisha;
Cui, Meizi;
Liu, Caigang

Publication type:

Article

Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.

Published in:

Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02005-y

By:

Gao, Hongli;
Xi, Zhuo;
Dai, Jingwei;
Xue, Jinqi;
Guan, Xin;
Zhao, Liang;
Chen, Zhiguang;
Xing, Fei

Publication type:

Article

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.

Published in:

2024

By:

Xing, Fei;
Gao, Hongli;
Chen, Guanglei;
Sun, Lisha;
Sun, Jiayi;
Qiao, Xinbo;
Xue, Jinqi;
Liu, Caigang

Publication type:

Correction Notice

Research progress in the role of IFN-γ in osteoimmunology.

Published in:

Chinese Journal of Osteoporosis, 2015, v. 21, n. 3, p. 361, doi. 10.3969/j.issn.1006-7108-2015.03.22

By:

FU Qin;
CHEN Zhiguang;
XUE Jinqi

Publication type:

Article

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes.

Published in:

Asian Journal of Pharmaceutical Sciences, 2023, v. 18, n. 3, p. 1, doi. 10.1016/j.ajps.2023.100814

By:

Xinbo Qiao;
Yixiao Zhang;
Zhan Zhang;
Nan Niu;
Haonan Li;
Lisha Sun;
Qingtian Ma;
Jiawen Bu;
Jinchi Liu;
Guanglei Chen;
Jinqi Xue;
Yongliang Yang;
Caigang Liu

Publication type:

Article

MAGP2 promotes osteogenic differentiation during fracture healing through its crosstalk with the β‐catenin pathway.

Published in:

Journal of Cellular Physiology, 2024, v. 239, n. 4, p. 1, doi. 10.1002/jcp.31183

By:

Chen, Zhiguang;
Zhao, Qi;
Chen, Lianghong;
Gao, Songlan;
Meng, Lingshuai;
Liu, Yingjie;
Wang, Yu;
Li, Tiegang;
Xue, Jinqi

Publication type:

Article

The altering in sensory sensitivity: a current issue of female breast surgery.

Published in:

International Journal of Medical Sciences, 2022, v. 19, n. 5, p. 901, doi. 10.7150/ijms.71913

By:

Tong Zhu;
Yi Jiang;
Ting Liu;
Jinqi Xue;
Nan Niu;
Jiawen Bu;
Mingxin Liu;
Caigang Liu;
Xudong Zhu;
Xi Gu

Publication type:

Article

CEMIP as a potential biomarker and therapeutic target for breast cancer patients.

Published in:

International Journal of Medical Sciences, 2022, v. 19, n. 3, p. 434, doi. 10.7150/ijms.58067

By:

Jinqi Xue;
Xudong Zhu;
Xinbo Qiao;
Yulun Wang;
Jiawen Bu;
Xiaoying Zhang;
Qingtian Ma;
Lu Liang;
Lisha Sun;
Caigang Liu

Publication type:

Article

Correction: Advances in immunotherapy for triple-negative breast cancer.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01858-z

By:

Liu, Yang;
Hu, Yueting;
Xue, Jinqi;
Li, Jingying;
Yi, Jiang;
Bu, Jiawen;
Zhang, Zhenyong;
Qiu, Peng;
Gu, Xi

Publication type:

Article

Advances in immunotherapy for triple-negative breast cancer.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01850-7

By:

Liu, Yang;
Hu, Yueting;
Xue, Jinqi;
Li, Jingying;
Yi, Jiang;
Bu, Jiawen;
Zhang, Zhenyong;
Qiu, Peng;
Gu, Xi

Publication type:

Article

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01716-y

By:

Xing, Fei;
Gao, Hongli;
Chen, Guanglei;
Sun, Lisha;
Sun, Jiayi;
Qiao, Xinbo;
Xue, Jinqi;
Liu, Caigang

Publication type:

Article

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer.

Published in:

MedComm, 2024, v. 5, n. 3, p. 1, doi. 10.1002/mco2.505

By:

Huo, Shiwen;
Xue, Jinqi;
Wang, Shuo;
Shan, Huilian;
Chen, Guanglei;
Niu, Nan;
Wang, Yimin;
Qiu, Fang;
Zhao, Yi;
Xing, Fei;
Zheng, Xinyu;
Tu, Wei;
Li, Ke;
Zhao, Hai;
Tang, Meiyue;
Xu, Qianshi;
Liu, Chao;
Zhao, Yafei;
Jiang, Xiaofan;
Pang, Zheng

Publication type:

Article